𝔖 Bobbio Scriptorium

✦ LIBER ✦

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

✍ Scribed by Yothers, G.; O'Connell, M. J.; Lee, M.; Lopatin, M.; Clark-Langone, K. M.; Millward, C.; Paik, S.; Sharif, S.; Shak, S.; Wolmark, N.

Book ID: 121424669
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 334 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.47.3116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the Levogyre and Dextro-Le

Comparison of the Levogyre and Dextro-Levogyre Forms of Leucovorin in a Phase III Trial of Bimonthly LV5FU2 Versus Monthly 5-Fluorouracil and High-Dose Leucovorin for Patients With Stage II and III Colon Cancer (GERCOR C96.1)

✍ Isabelle Baumgaertner; Emmanuel Quinaux; Ahmed Khalil; Christophe Louvet; Marc B 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 540 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB